Deep Analysis of Oklo Inc. (OKLO)#

Sector: Utilities / Energy (Advanced Nuclear Technology)

Industry: Advanced Nuclear Reactors / Small Modular Reactors (SMR)

This article is for informational purposes only and is not investment advice. Figures were gathered from public sources listed at the end.

Introduction#

Oklo Inc. is a Santa Clara, California-based advanced nuclear technology company developing fast-fission “powerhouses” to deliver clean baseload electricity, with a primary focus on the surging power needs of AI data centers and industrial customers. Oklo is building small modular reactors meant to provide clean, dependable baseload power for commercial and industrial uses, including AI data centers. Its flagship product, the Aurora Powerhouse, is a sodium/heat-pipe fast reactor designed to produce roughly 15 to 75 megawatts of electricity. The company’s distinguishing strategy is a vertically integrated “build-own-operate” model — it intends to sell power under long-term agreements rather than selling reactors, while also building parallel revenue streams in radioisotopes and nuclear fuel recycling. Backed by OpenAI’s Sam Altman (former chairman) and carrying a roughly $10 billion market capitalization, Oklo is one of the most closely watched — and most speculative — names in the nuclear renaissance.

Fundamental Analysis#

Oklo presents the classic profile of a well-capitalized, pre-revenue development-stage company: an exceptionally strong balance sheet paired with mounting losses and no meaningful sales yet. Financially, its solvency is not in question for the near term, but its valuation rests almost entirely on future execution rather than current earnings. Oklo currently reports no revenue, and analysts have flagged that it makes less than US$1m, so execution risk is still high.

• Cash fortress, essentially debt-free. As of March 31, 2026, Oklo held $1.594 billion in cash and equivalents plus roughly $943 million in marketable securities (current and non-current), with total assets of about $2.70 billion and total stockholders’ equity of $2.64 billion against minimal liabilities. Management raised $1.2 billion through an at-the-market (ATM) program, and analysts note the balance sheet now removes near-term funding risk.
• Widening losses, no revenue. Net loss widened to $33.1 million from $9.8 million in the year-ago period, driven mostly by rising operational expenses. Operating expenses jumped to roughly $51.2 million from $17.9 million a year prior.
• Heavy build-mode spending guidance. For 2026, management is guiding to $80 million–$100 million in operating cash burn and $350 million–$450 million in capex.
• Valuation is rich and speculative. The stock trades at roughly $57 with a ~$10 billion market cap, a price-to-book ratio of 4.34 times, more than double the energy sector’s median of 1.99 times. EPS (TTM) is about -$0.83 and beta is ~2.47.
• Dilution risk. Funding multiple projects under a build-own-operate model, along with a US$1b follow-on equity program and prior dilution, raises ongoing capital needs and the risk of further shareholder dilution.
• Wide analyst dispersion. Targets range enormously, from about $14 to $140, with a consensus near $88–$92, reflecting deep uncertainty about whether the pipeline converts to cash.

Key Products or Services#

Oklo’s commercial story rests on a “sell power, not power plants” model anchored by the Aurora reactor, supplemented by two adjacent revenue lines — radioisotopes and fuel recycling — that are designed to generate cash earlier than commercial reactor power. Oklo’s Aurora powerhouse is a fast neutron reactor that uses heat pipes to transport heat from the reactor core to a supercritical carbon dioxide power conversion system to generate electricity, building on the design heritage of the Experimental Breeder Reactor II (EBR-II) and using metallic fuel from fresh HALEU or used nuclear fuel.

• Aurora Powerhouse (core product): A scalable fast-fission plant of ~15–75 MWe (with 100+ MW designs being explored), sold via long-term power purchase agreements (PPAs). The first unit, Aurora-INL, is under construction at Idaho National Laboratory.
• Build-own-operate model: Oklo builds Aurora Powerhouses and sells electricity on long-term power purchase agreements; the customer gets guaranteed clean baseload power at a contracted price, and Oklo gets recurring revenue for the life of the plant.
• Radioisotopes (Atomic Alchemy): A near-term, higher-margin revenue path. The NRC granted Atomic Alchemy a materials license in March 2026 to work with Radium-226, Cobalt-60, and Americium-241, providing a near-term revenue pathway while Aurora works through licensing. The Groves Isotopes Test Reactor in Texas targets criticality by July 4, 2026.
• Nuclear fuel recycling: Oklo is building an Advanced Fuel Center in Tennessee to recycle spent fuel for use in its own reactors.
• Fuel-cycle joint venture (Centrus): Oklo and Centrus Energy are exploring a joint venture for HALEU deconversion at Centrus’ Piketon, Ohio site, near Oklo’s planned 1.2-gigawatt power campus.

Moats, Strengths and Weaknesses#

Moats#

• Regulatory head start within the DOE fast-track. Oklo holds a unique position in the DOE pilot program: while every other company has only one project selected for acceleration, Oklo has three.
• Vertical integration. The build-own-operate model plus in-house fuel fabrication, recycling, and (via the ARMEC acquisition) precision manufacturing creates control over the deployment chain that pure technology licensors lack.
• Fuel heritage and access. Aurora builds on proven EBR-II technology and Oklo secured access to recovered HALEU fuel from the historic reactor through a competitive DOE process.
• Founder/strategic backing and brand. Association with Sam Altman and proximity to the AI-power thesis gives Oklo outsized visibility and capital access.

Strengths#

• A pristine, largely debt-free balance sheet with ~$2.5 billion in cash and securities to self-fund years of development.
• A large contracted-interest pipeline. Oklo has non-binding letters of intent totaling approximately 14 gigawatts of contracted pipeline, including a 12 GW data center deal with Switch and a 1.2 GW Meta campus in Ohio.
• Multiple revenue streams (power, isotopes, fuel) that diversify the path to first cash.
• Marquee partnerships with Meta, NVIDIA, Los Alamos National Laboratory, Siemens Energy, and Centrus.

Weaknesses#

• Zero revenue and widening losses, with profitability not forecast within three years.
• No NRC commercial operating license yet. What Oklo really needs is approval from the NRC for its Aurora Powerhouses to operate commercially — its DOE/NRC wins so far cover safety frameworks and isotopes, not commercial power.
• Pipeline is largely non-binding. These are non-binding letters of intent, not signed contracts with payment obligations; they represent customer interest, not committed capital.
• Fuel supply bottleneck. HALEU and plutonium-based fuel remain scarce, a constraint Oklo itself flags.
• High capital intensity and dilution risk inherent to owning and operating its plants.
• Timeline risk: first commercial power revenue is not expected until late 2027 at the earliest.

News, Events and Partnerships#

The trailing 180 days (December 2025–June 2026) have been among the most eventful in Oklo’s history, dominated by a cadence of regulatory approvals, major commercial agreements, and a strategic acquisition — broadly positive for the long-term narrative, though insider selling and a wide loss have weighed on the stock.

• Jan 7, 2026 (positive): Oklo and DOE partnered to deploy a radioisotope pilot facility supporting cancer care and U.S. medical supply chains.
• Jan 9, 2026 (positive): Oklo and Meta announced an agreement supporting 1.2 GW of nuclear energy development in Southern Ohio to power Meta’s AI operations, including its New Albany supercluster.
• Jan 22, 2026 (positive): President Trump’s pro-nuclear comments at Davos lifted Oklo, NuScale, and Nano Nuclear; BofA upgraded Oklo to Buy with a $111 target.
• Mar 9, 2026 (positive): Centrus HALEU deconversion JV announced in Piketon, Ohio.
• Mar 17, 2026 (positive): The NRC issued Atomic Alchemy a materials license — Oklo’s first NRC-issued license — alongside DOE NSDA approvals for both the Aurora-INL and the Groves isotopes reactor.
• Apr 23, 2026 (positive): Oklo announced a three-way partnership with Nvidia and Los Alamos National Laboratory to use AI and advanced simulation to design next-generation reactors and fuel; shares rallied 15.65%.
• May 12, 2026 (mixed/negative): Q1 results showed a wider $33.1M loss; the stock sold off despite the cash cushion.
• Jun 4–5, 2026 (positive): Oklo closed the acquisition of ARMEC, an Oak Ridge precision manufacturing firm with ~40 staff and positive free cash flow, and the DOE’s Idaho Operations Office approved the Preliminary Documented Safety Analysis (PDSA) for the Aurora powerhouse — a key authorization milestone.

Government Integration#

Oklo is arguably the single most government-entangled name in the advanced-nuclear space, with three projects inside the DOE’s Reactor Pilot Program and deep ties to the current administration’s energy agenda. The relationship is overwhelmingly a tailwind, though it also draws political scrutiny. Oklo signed a DOE Other Transaction Agreement to support the design, construction, and operation of its Aurora facility at INL under the Reactor Pilot Program, established by President Trump’s May 2025 Executive Order 14301.

• Reactor Pilot Program (RPP): Established under EO 14301 with a target of at least three test reactors achieving criticality using the DOE authorization process by July 4, 2026.
• Aurora-INL authorization pathway: NSDA approved (March), PDSA approved (June) — a stepwise DOE path that Oklo says can be fast-tracked to future NRC licensing.
• Fuel facilities: DOE approved the Nuclear Safety Design Agreement for Oklo’s Aurora Fuel Fabrication Facility (A3F) and granted access to ~5 metric tons of HALEU from EBR-II.
• Isotope reactor (Groves, Texas): DOE-approved NSDA; targeting criticality by July 4, 2026.
• Surplus Plutonium Utilization Program: Oklo joined the DOE’s Surplus Plutonium Utilization Program in partnership with newcleo, targeting advanced fuel sourcing.
• Lobbying: Oklo has spent roughly $250,000 per quarter lobbying on energy/nuclear, defense, and appropriations issues.
• Political optics: Energy Secretary Chris Wright resigned from Oklo’s board upon taking office, complied with disclosure rules, and never owned Oklo stock, after Senator Markey raised conflict-of-interest concerns over DOE plutonium decisions.

Social Sentiment#

Retail sentiment toward Oklo is intensely engaged and broadly bullish on the long-term thesis, but volatile and highly news-driven on a day-to-day basis, frequently swinging between “bullish” and “bearish” on StockTwits around catalysts. Reddit sentiment has held bullish across the week (65.6), month (62.5), and quarter (64.7), spiking to 72 in late February after coverage of Oklo’s confidence in hitting the DOE’s July 4 reactor criticality deadline. On StockTwits, message volumes routinely surge 150%+ around announcements, and around the NVIDIA partnership retail sentiment for OKLO turned “extremely bullish” from “bullish” amid “extremely high” message volumes. The dominant retail narrative frames Oklo as a “picks-and-shovels” play on the AI energy bottleneck, with bulls citing $100+ price targets; bears focus on the lack of revenue, lofty valuation, and the gap between hype and the late-2027 commercial timeline. Sentiment has cooled somewhat in 2026 as the stock fell well off its $193 high, but conviction in the underlying nuclear-AI story has remained intact.

Insider Activity#

Insider activity over the past six months has been consistently and exclusively to the sell side, with no open-market insider purchases recorded. Co-founders Jacob DeWitte (CEO) and Caroline Cochran (COO) have repeatedly sold shares under a pre-arranged Rule 10b5-1 trading plan adopted on March 31, 2025. In early January 2026, the co-founders reported stock sales totaling over $50 million under pre-arranged Rule 10b5-1 plans, with further sales in February (~$1.5M), March, May, and a 200,000-share sale on June 1, 2026 at prices between $64.99 and $70.45. Importantly, the sales were scheduled in advance and the founders retain very large positions (millions of shares across direct holdings, GRATs, and family trusts), so the activity is best read as routine, pre-planned liquidity management rather than a directional signal. Still, the optics of steady, sizable insider selling into a momentum stock — and the absence of any insider buying — is a point bears reliably highlight.

Politician Activity#

There is no recorded congressional trading in Oklo. Quiver Quantitative’s tracker reports “No Congressional activity found for this ticker,” meaning no U.S. senators or representatives have disclosed buying or selling OKLO under the STOCK Act in the available data. The more relevant political dimension is structural rather than transactional: Oklo sits at the center of the administration’s nuclear agenda, and its government ties have attracted oversight, most notably Senator Markey’s September 2025 letter questioning Energy Secretary Chris Wright’s prior role on Oklo’s board and potential conflicts over DOE plans to provide plutonium to the company. Investors should weigh that Oklo’s fortunes are tightly coupled to federal policy continuity, which is itself a political risk in either direction.

Institutional Activity#

Institutional ownership is broad and substantial, dominated by large index/passive managers with active participation from quant and hedge funds — a sign the stock is firmly in the institutional universe even as it remains speculative. Oklo has 701 institutional owners holding a total of roughly 74.4 million shares, with the largest including BlackRock, Vanguard, Mirae Asset, Jane Street, Susquehanna, Citadel Advisors, Van Eck, and State Street.

• Bullish / accumulation signals: BlackRock reported beneficial ownership of 14,419,350 shares, representing 9.2% of outstanding shares. Cathie Wood’s ARK Investment increased its stake, buying over 34,000 shares following earlier acquisitions valued at more than $8.9 million. Vanguard’s position (~8.7M shares) and heavy ETF inclusion (e.g., the Global X Uranium ETF holds OKLO at ~11% weight) reflect structural demand.
• Bearish / caution signals: A shareholder filed notice to sell 655,000 Class A shares (~$62.6M) around early January 2026, and analyst commentary has flagged that peers like Constellation fell on downgrades challenging “AI-nuclear premium valuations broadly,” a multiple-compression risk that applies to Oklo. Sell-side ratings cluster at “Moderate Buy,” but with several Holds and a very wide target range, signaling divided institutional conviction.

Political Landscape#

The current macro and policy backdrop is unusually favorable for advanced nuclear and forms the core of the bull case, though it comes with execution and commodity-supply risks. The defining drivers are AI-driven electricity demand and an aggressive federal push for “energy dominance.” Recent executive orders aim to increase US nuclear energy capacity from 100GW to 400GW by 2050, and the DOE is working to remove barriers to co-locating data centers with new generation, including on federal land.

• AI power demand surge: U.S. data center electricity demand is projected to grow from 176 terawatt hours to as high as 580 terawatt hours by 2028, with AI-driven consumption outpacing available grid capacity in multiple regions.
• Aggressive federal policy: A suite of 2025–2026 executive orders (14300 reforming the NRC, 14301 on reactor testing, plus AI-infrastructure orders) set fixed licensing deadlines and created the Reactor Pilot Program; EO 14300 calls for no more than 18 months for new-reactor construction-and-operation application decisions once implementing rules are finalized.
• Funding and supply-chain support: In January 2026 the DOE announced a $2.7 billion investment to strengthen domestic enrichment, and in December 2025 awarded $800 million to TVA and Holtec to advance U.S. small modular reactors.
• Space/defense angle: On April 14, the White House mandated space nuclear deployment by 2028 and lunar reactors by 2030, lifting the nuclear sector.
• Geopolitical/commodity tailwind and risk: Spot uranium prices crossed $100/lb early in 2026 amid an AI-driven demand surge, a Russian uranium import ban, and a structural supply deficit — supportive for nuclear broadly, but the HALEU bottleneck specifically constrains fast-reactor developers like Oklo.

The Competition#

Companies compared: NuScale Power (SMR), Nano Nuclear Energy (NNE), Centrus Energy (LEU)

NuScale Power (SMR)#

NuScale is Oklo’s most direct head-to-head competitor in small modular reactors, and the clearest contrast in strategy: NuScale licenses a proven light-water design rather than owning and operating plants, and it is the regulatory front-runner. NuScale is the only SMR technology provider with a U.S. NRC-approved design, an established supply chain, and components currently in production for commercial use. Its deliberate use of conventional fuel sidesteps the HALEU supply problem that constrains Oklo.

• Regulatory lead: The only SMR developer with NRC standard design approval (50 MWe and 77 MWe modules).
• Fuel advantage: Runs on widely available low-enriched uranium (LEU), avoiding the HALEU bottleneck.
• Marquee program: Its ENTRA1/TVA agreement covers up to 6 gigawatts of SMR deployment, described as the largest SMR program in the U.S.
• Financials: Ended Q1 2026 with $1 billion in liquidity; Q1 2026 revenue fell to $0.6 million from $13.4 million a year earlier. Stock trades around $12 with a consensus target near $17.

Nano Nuclear Energy (NNE)#

Nano Nuclear is a smaller, earlier-stage competitor targeting the microreactor niche (sub-Aurora scale), which makes it adjacent rather than perfectly overlapping, but it competes for the same DOE support, fuel supply, and “vertically integrated nuclear” investment narrative. Nano Nuclear operates as a microreactor technology company developing solid-core battery and low-pressure coolant reactors alongside a HALEU fuel and transportation business. It has recently hit notable licensing milestones.

• Regulatory progress: The NRC formally accepted the Construction Permit Application for its KRONOS MMR microreactor at the University of Illinois Urbana-Champaign — among the first microreactors to reach this stage.
• Vertical integration: Five business lines spanning microreactors, fuel fabrication, fuel transportation (via its STS acquisition), space applications, and consulting.
• Government support: Awarded a DOE GAIN voucher with Oak Ridge National Laboratory for reactor-design validation.
• Stage: Pre-revenue with a much smaller market cap; the highest risk/reward and least proven of the group.

Centrus Energy (LEU)#

Centrus is both a competitor-adjacent fuel supplier and Oklo’s JV partner, and it is by far the most financially mature company in this comparison — it sells the enriched uranium that advanced reactors require. Centrus’s FY2025 revenue came in at $448.7 million, with a $3.8 billion total backlog extending to 2040 and a $900 million DOE HALEU production task order. It is the strategic linchpin of domestic fuel supply.

• Only U.S. licensed HALEU producer, central to solving the very bottleneck that constrains Oklo and other fast-reactor developers.
• Real revenue and backlog: Unlike the pure reactor developers, Centrus is already generating substantial sales; its stock has risen 211% over the past year.
• DOE-anchored: Its HALEU production contract runs through mid-2026 with options to extend eight additional years.
• Partner and competitor: It is building Oklo’s Piketon fuel JV while also supplying the broader industry, including NuScale.

How Oklo stacks up#

Oklo’s position is best understood as the highest-conviction, highest-risk way to bet on advanced nuclear powering AI. Versus NuScale, Oklo trades the safety of an NRC-approved, fuel-available design for a more differentiated, vertically integrated build-own-operate model with a far larger contracted pipeline — but it carries more regulatory and fuel-supply risk and a richer valuation. Versus Nano Nuclear, Oklo is larger, better capitalized, and further along commercially. Versus Centrus, Oklo offers reactor-level upside but lacks the real revenue, backlog, and proven cash generation that make Centrus the “shovels” of the trade.

The market reflects this: on near-term fundamentals, the cautious view favors the names with revenue or regulatory clarity. SMR’s NRC approvals, LEU fuel advantage, lower valuation, and better earnings estimate profile make it look slightly better positioned at the moment, and both OKLO and SMR carry a neutral Zacks “Hold.” Oklo’s edge is optionality — the multi-stream model (power, isotopes, recycling), the deepest DOE entanglement (three pilot projects), and the strongest balance sheet among the reactor developers.

Metric	Oklo (OKLO)	NuScale (SMR)	Nano Nuclear (NNE)	Centrus (LEU)
Focus	Fast-fission powerhouses + isotopes + recycling	Light-water SMR (licensor)	Microreactors + fuel	Uranium enrichment / HALEU
Revenue status	Pre-revenue (~$0)	Minimal (~$0.6M Q1’26)	Pre-revenue	~$448.7M FY2025
NRC commercial design approval	No (isotope license only)	Yes (only SMR)	CPA accepted	N/A (fuel supplier)
Fuel	HALEU/recycled (scarce)	LEU (available)	HALEU	Produces LEU/HALEU
Balance sheet	~$2.5B cash, ~debt-free	~$1B+ liquidity	Smaller cash base	Revenue-generating, backlog $3.8B
Approx. market cap	~$10B	~$3–4B range	Small-cap	Mid-cap (stock +211% 1yr)
Key catalyst	July 4 criticality; NRC licensing	TVA-ENTRA1 6 GW; RoPower	KRONOS CPA review	DOE HALEU contract extension

The Proxy#

Centrus Energy (LEU)#

Centrus is the strongest proxy for the Oklo thesis for investors who want exposure to the advanced-nuclear / AI-power supercycle but with materially lower binary risk. It is “picks and shovels” for the entire sector: every fast reactor — Oklo’s included — needs the HALEU that Centrus is uniquely licensed to produce in the U.S., so Centrus benefits from the same secular tailwinds (AI demand, federal funding, the Russian uranium ban, the 100→400 GW target) without depending on any single reactor developer’s NRC timeline. It is also literally a partner, building Oklo’s Piketon fuel JV.

• Same tailwind, less single-name risk: Profits from advanced-reactor adoption broadly rather than betting on one design clearing the NRC.
• Real fundamentals today: FY2025 revenue of $448.7 million and a $3.8 billion backlog to 2040 — a sharp contrast to Oklo’s pre-revenue status.
• Government-anchored demand: Backed by a $900M DOE HALEU task order and the January 2026 $2.7B federal enrichment push.
• Directly linked to Oklo: The JV at Piketon ties Centrus’s growth to Oklo’s deployment while diversifying across the whole reactor industry.
• Trade-off: Less explosive upside than a successful Oklo reactor rollout, and exposure to uranium-price and contract-timing volatility.

The Big Picture for Oklo#

Oklo enters mid-2026 as one of the best-positioned companies to ride a genuine structural shift: the collision of exploding AI electricity demand with an administration treating nuclear power as a national-security priority. The directional alignment between Oklo’s product and where the market is heading over the next five-to-ten years is about as strong as it gets — the world needs vast amounts of firm, carbon-free, behind-the-meter baseload power, and Oklo’s small, scalable, build-own-operate powerhouses are designed precisely for hyperscale data centers and industrial loads. A ~14 GW pipeline anchored by Meta, Switch, and NVIDIA-adjacent demand, three DOE pilot projects, a debt-free balance sheet, and multiple revenue streams (power, isotopes, recycling) give it more shots on goal than almost any peer.

The central question is execution and timing, not relevance. Oklo’s offerings are clearly in alignment with the market’s direction; the risk is whether the company can convert that alignment into cash before patience and capital constraints bite. The Aurora powerhouse won’t generate commercial revenue until roughly late 2027 at the earliest, and that depends on NRC commercial licensing it has not yet obtained — the DOE pilot pathway and the isotope license are real progress but are not the same thing. The HALEU/plutonium fuel bottleneck is a genuine constraint that even a flawless reactor design cannot wish away, which is part of why the Centrus fuel JV and the newcleo plutonium partnership matter so much.

In the near term, the July 4, 2026 criticality milestone at the Atomic Alchemy Groves reactor is the most concrete catalyst, and isotope sales offer the first realistic revenue. If Oklo can demonstrate criticality on the DOE timeline, begin booking isotope and recycling revenue, and convert one or two of its non-binding LOIs (especially Meta’s) into binding, prepaid contracts, the “story stock” reframes into an early-stage operating company — and the wide analyst target dispersion ($14 to $140) should begin to compress upward. The vertical integration push, capped by the ARMEC acquisition, signals management is building the muscle to actually deploy rather than just design.

The bear case is equally coherent and should not be dismissed. Oklo is priced for substantial future success at ~4.3x book and a ~$10B cap on zero revenue, leaving little margin for delay; insider selling is steady; dilution is a recurring feature of the build-own-operate model; and a broader de-rating of “AI-nuclear premium” valuations (as already seen in peers) could compress Oklo’s multiple regardless of operational progress. A single major regulatory delay, a soured marquee partnership, or a cooling of the AI capex cycle could hit the stock hard.

On balance, Oklo looks like a company whose product roadmap is well-matched to where energy markets are going — it is far more likely to be a beneficiary of the next decade’s demands than to be left behind — but it remains a high-variance, execution-dependent investment where the timeline to revenue, the NRC pathway, and fuel supply are the decisive variables. It is positioned to win if the advanced-nuclear thesis plays out, but the gap between a 14 GW pipeline of intentions and 14 GW of operating, revenue-generating reactors is exactly where the risk — and the opportunity — lives.

Sources#

• Oklo Inc. Q1 2026 Form 10-Q (SEC) — balance sheet and financials
• Barchart — DOE win / Q1 2026 results; ARMEC acquisition analysis and 2026 guidance
• Investing.com, Morningstar, CNBC, CNN, TradingView, eToro, StockAnalysis, Public.com — price, market cap, analyst targets, and market data
• World Nuclear News (multiple) — Aurora-INL NSDA/PDSA, fuel facility approvals, licensing progress
• Nuclear Engineering International; ANS Nuclear Newswire; NucNet — Reactor Pilot Program detail and groundbreaking
• Oklo Inc. newsroom / press releases — PDSA approval, NSDA approval, Atomic Alchemy NRC license, Meta agreement, ARMEC acquisition
• ZeroHedge, The Motley Fool, TECHi, IndexBox, StockTitan — NRC isotope license and regulatory analysis
• Bitget, Yahoo Finance / Simply Wall St — customer pipeline, Meta/NVIDIA/Switch partnerships, risk flags
• Utility Dive, Carbon Credits, PowerMag — Switch 12 GW master agreement; Liberty/Vertiv alliances
• StockTitan, Quiver Quantitative, Investing.com, Insider Dashboard — insider Form 4 filings and SEC filing tracking
• Quiver Quantitative (congress trading, institutional holdings, lobbying) — no congressional activity; institutional and lobbying data
• Benzinga / Inkl — Markey letter on Energy Secretary Chris Wright’s Oklo ties
• Fintel, Holdings Channel — institutional ownership totals and top holders
• StockTwits, 24/7 Wall St., AltIndex — Reddit and StockTwits social-sentiment data
• Foreign Policy Journal, Finviz, MarketScreener — analyst ratings and NVIDIA/LANL partnership
• SEC filings for Nano Nuclear (NNE) Form 8-Ks; NuScale (SMR) Q1 2026 8-K and earnings call transcripts
• The Motley Fool, TradingView/Zacks, Simply Wall St, Energy Central — competitor comparisons (SMR, NNE, LEU)
• U.S. Department of Energy fact sheets (energy.gov) — executive orders, RPP, enrichment investment, SMR awards
• Carbon Credits, Shale Magazine, Crux Investor, Data Center Knowledge, Brookings, IAEA, PR Newswire, Kalkine — macro nuclear/AI-energy landscape